Daniel Pérez-Pérez

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Temporal Lobe Epilepsy

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Pérez-Pérez, Cristina Monío-Baca, Eva-Lotta von Rüden, Verena Buchecker, Amelie Wagner, Katharina Schönhoff, Liga Zvejniece, Dennis Klimpel, Heidrun Potschka
Preclinical efficacy profiles of the sigma-1 modulator E1R and of fenfluramine in two chronic mouse epilepsy models. Epilepsia 65 (8) (2024)
Daniel Pérez-Pérez, Cristina Monío-Baca, Eva-Lotta von Rüden, Verena Buchecker, Amelie Wagner, Katharina Schönhoff, Liga Zvejniece, Dennis Klimpel, Heidrun Potschka
Preclinical efficacy profiles of the sigma-1 modulator E1R and of fenfluramine in two chronic mouse epilepsy models. Epilepsia 65 (8) (2024)
Cesar Emmanuel Santana-Gómez, Daniel Pérez-Pérez, Daniel Fonseca-Barriendos, Oscar Arias-Carrión, Walter G Besio, Luisa Rocha
Transcranial Focal Electrical Stimulation Modifies Biogenic Amines' Alterations Induced by 6-Hydroxydopamine in Rat Brain. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Daniel Fonseca-Barriendos, Christian Lizette Frías-Soria, Daniel Pérez-Pérez, Rosenda Gómez-López, Dasiel O Borroto Escuela, Luisa Rocha
Drug-resistant epilepsy: Drug target hypothesis and beyond the receptors. Epilepsia open (2021)
Daniel Pérez-Pérez, Iannel Reyes-Vidal, Elda Georgina Chávez-Cortez, Julio Sotelo, Roxana Magaña-Maldonado
Methylxanthines: Potential Therapeutic Agents for Glioblastoma. Pharmaceuticals (Basel, Switzerland) 12 (3) (2019)